Cisplatin

 

Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose

Cisplatin Pharmacokinetics in Children with Cancer

Cisplatin-Induced Hyperactivity in the Dorsal Cochlear Nucleus and Its Relation to Outer Hair Cell Relevance to Tinnitus

Influence of Cellular Factors and Pharmacokinetics on the Formation of Platinum-DNA Adducts in Leukocytes of Children Receiving Cisplatin Therapy1

Protective eVect of T-type calcium channel blocker Xunarizine on cisplatin-induced death of auditory cells

Hsp90 Inhibitors Deplete Key Anti-Apoptotic Proteins in Pediatric Solid Tumor Cells and Demonstrate Synergistic Anticancer Activity With Cisplatin

Intra-Arterial Cisplatin in Osteosarcoma: Same Question, Different Answe

Ototoxicity in Children Receiving Platinum Chemotherapy: Underestimating a Commonly Occurring Toxicity That May Influence Academic and Social Developmen

Cisplatin (CDDP) speci®cally induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma

Expression of Kinase Suppressor of Ras1 Enhances Cisplatin-Induced Extracellular Signal–Regulated Kinase Activation and Cisplatin Sensitivity

Renal Toxicity Caused by Cisplatinum in Glutathione-Depleted Metallothionein-Null Mice